Company intelligence / Profile preview

Abiochem Biotechnology

Shanghai, Shanghai, Chinaabiochem.com ↗

Ownership: Private
Development stage: Other

Overview

Abiochem is a commercial-stage biotech specializing in the development and large-scale production of enzymes, active pharmaceutical ingredients (APIs), chemical intermediates, and custom synthesis using advanced genetic and enzyme engineering technologies. The company’s biosynthetic processes are applied to pharmaceuticals as well as health care and agrochemical sectors. It operates one of China’s largest enzyme libraries for screening and modification to support its contract research (CRO) & manufacturing (CMO) services

Therapeutic areas: Other
Modalities: EnzymeSmall moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Serves global pharma/biotech clients through CRO/CMO relationships

Beyond the preview

Go deeper on Abiochem Biotechnology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Abiochem Biotechnology.

Explore the full profile